Latest news
Aprea Therapeutics, Inc. (APRE) stock price, news, quote and history - Yahoo Finance SingaporeYahoo Finance Singapore · Fri, 07 Aug 2026 13:57:51 GMTAprea Therapeutics Provides Acesot-1051 Program Update For Wee1 Inhibitor Apr-1051 Accelerating And Expanding Enrollment. Clinical Data Presentation Planned For Q4 2026 - TradingViewTradingView · Thu, 30 Jul 2026 07:00:00 GMTAprea Plans APR-1051 Cancer Combinations as Trial Sites Rise 3 to 10 - Stock TitanStock Titan · Thu, 30 Jul 2026 07:00:00 GMTAPRE|Aprea Therapeutics Inc|Price:0.607|Chg%:-0.013 - TradingKeyTradingKey · Thu, 30 Jul 2026 07:00:00 GMTQ&A: Aprea Therapeutics' Oren Gilad on WEE1 Inhibitor Data and the Company's DNA Damage Response Strategy - BioPharm InternationalBioPharm International · Wed, 29 Jul 2026 07:00:00 GMT